ES8304585A1 - Procedimiento para preparar 18-sustituidas pregn-4-ene-3,20-dionas - Google Patents
Procedimiento para preparar 18-sustituidas pregn-4-ene-3,20-dionasInfo
- Publication number
- ES8304585A1 ES8304585A1 ES505051A ES505051A ES8304585A1 ES 8304585 A1 ES8304585 A1 ES 8304585A1 ES 505051 A ES505051 A ES 505051A ES 505051 A ES505051 A ES 505051A ES 8304585 A1 ES8304585 A1 ES 8304585A1
- Authority
- ES
- Spain
- Prior art keywords
- production
- pharmaceutical compositions
- progesterone derivatives
- substituent
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polyamides (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE 18-SUSTITUIDAS PREGN-4-ENE-3-20-DIONAS, DE FORMULA (I), EN LA QUE Y Y Z SON HIDROGENO O HIDROXI; Y R ES 2-ALQUINILO C <- . CONSISTE EN LA REACCION DE UN 13-(3-CLORO-2-PROPENIL)ESTEROIDE CON UNA BASE FUERTE TAL COMO LITIO DIISOPROPILAMIDA O AMIDA DE LITIO EN AMONIACO; SEGUIDA DE LA ELIMINACION DE GRUPOS PROTECTORES DE CETAL, POR TRATAMIENTO CON ACIDO, Y, FINALMENTE, ELIMINACION DE GRUPOS PROTECTORES DE ESTER POR HIDROLISIS ALCALINA. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DEL HIPERALDOSTERONISMO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/183,534 US4293548A (en) | 1980-09-02 | 1980-09-02 | 18-Substituted pregn-4-ene-3,20-diones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8304585A1 true ES8304585A1 (es) | 1983-03-01 |
| ES505051A0 ES505051A0 (es) | 1983-03-01 |
Family
ID=22673212
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES505051A Granted ES505051A0 (es) | 1980-09-02 | 1981-08-28 | Procedimiento para preparar 18-sustituidas pregn-4-ene-3,20-dionas |
| ES518145A Expired ES8404375A1 (es) | 1980-09-02 | 1982-12-13 | Procedimiento para preparar 18-sustituidas pregn-4-ene-3,20-dionas y compuestos especificos de 18-eti ilpregn- y vinilidenopregn-4-eno-3,20-diona. |
| ES529488A Expired ES8506046A1 (es) | 1980-09-02 | 1984-02-06 | Procedimiento para preparar 18-sustituidas pregn-4-ene-3, 20-dionas y compuestos especificos de 18-etinilpregn- y vinilidenopregn-4-eno-3, 20-diona |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES518145A Expired ES8404375A1 (es) | 1980-09-02 | 1982-12-13 | Procedimiento para preparar 18-sustituidas pregn-4-ene-3,20-dionas y compuestos especificos de 18-eti ilpregn- y vinilidenopregn-4-eno-3,20-diona. |
| ES529488A Expired ES8506046A1 (es) | 1980-09-02 | 1984-02-06 | Procedimiento para preparar 18-sustituidas pregn-4-ene-3, 20-dionas y compuestos especificos de 18-etinilpregn- y vinilidenopregn-4-eno-3, 20-diona |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4293548A (es) |
| EP (1) | EP0047016B1 (es) |
| JP (1) | JPS5777698A (es) |
| AT (1) | ATE4645T1 (es) |
| AU (1) | AU542864B2 (es) |
| CA (1) | CA1175041A (es) |
| DE (1) | DE3160879D1 (es) |
| DK (1) | DK161255C (es) |
| ES (3) | ES505051A0 (es) |
| IE (1) | IE51578B1 (es) |
| IL (1) | IL63680A (es) |
| NO (1) | NO157176C (es) |
| NZ (1) | NZ198190A (es) |
| PH (1) | PH17253A (es) |
| ZA (1) | ZA815963B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4910191A (en) * | 1988-06-28 | 1990-03-20 | Merrell Dow Pharmaceuticals Inc. | 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
| US4920114A (en) * | 1988-06-28 | 1990-04-24 | Merrell Dow Pharmaceuticals Inc. | 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3796728A (en) * | 1967-06-06 | 1974-03-12 | Schering Corp | Steroidal derivatives,methods for their manufacture,and compounds produced thereby |
| GB1247661A (en) * | 1967-07-11 | 1971-09-29 | Philips Nv | NEW 9beta,10alpha-STEROIDS AND METHODS OF PRODUCING THE SAME |
| SE374363B (es) * | 1967-12-22 | 1975-03-03 | Ciba Geigy Ag | |
| CH606101A5 (es) * | 1975-01-30 | 1978-10-13 | Ciba Geigy Ag |
-
1980
- 1980-09-02 US US06/183,534 patent/US4293548A/en not_active Expired - Lifetime
-
1981
- 1981-08-27 ZA ZA815963A patent/ZA815963B/xx unknown
- 1981-08-27 DK DK380881A patent/DK161255C/da not_active IP Right Cessation
- 1981-08-27 CA CA000384716A patent/CA1175041A/en not_active Expired
- 1981-08-27 AU AU74759/81A patent/AU542864B2/en not_active Ceased
- 1981-08-27 IL IL63680A patent/IL63680A/xx not_active IP Right Cessation
- 1981-08-27 PH PH26114A patent/PH17253A/en unknown
- 1981-08-27 NZ NZ198190A patent/NZ198190A/en unknown
- 1981-08-28 ES ES505051A patent/ES505051A0/es active Granted
- 1981-08-31 JP JP56135639A patent/JPS5777698A/ja active Granted
- 1981-08-31 IE IE1990/81A patent/IE51578B1/en not_active IP Right Cessation
- 1981-09-01 NO NO812957A patent/NO157176C/no not_active IP Right Cessation
- 1981-09-01 EP EP81106838A patent/EP0047016B1/en not_active Expired
- 1981-09-01 AT AT81106838T patent/ATE4645T1/de not_active IP Right Cessation
- 1981-09-01 DE DE8181106838T patent/DE3160879D1/de not_active Expired
-
1982
- 1982-12-13 ES ES518145A patent/ES8404375A1/es not_active Expired
-
1984
- 1984-02-06 ES ES529488A patent/ES8506046A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NZ198190A (en) | 1984-03-16 |
| DK161255C (da) | 1992-01-06 |
| CA1175041A (en) | 1984-09-25 |
| IL63680A0 (en) | 1981-11-30 |
| ES529488A0 (es) | 1985-07-01 |
| US4293548A (en) | 1981-10-06 |
| NO812957L (no) | 1982-03-03 |
| IE811990L (en) | 1982-03-02 |
| AU542864B2 (en) | 1985-03-21 |
| EP0047016B1 (en) | 1983-09-14 |
| ES505051A0 (es) | 1983-03-01 |
| IL63680A (en) | 1985-05-31 |
| NO157176C (no) | 1988-06-01 |
| ATE4645T1 (de) | 1983-09-15 |
| DK380881A (da) | 1982-03-03 |
| JPS5777698A (en) | 1982-05-15 |
| PH17253A (en) | 1984-07-03 |
| IE51578B1 (en) | 1987-01-21 |
| DE3160879D1 (en) | 1983-10-20 |
| DK161255B (da) | 1991-06-17 |
| NO157176B (no) | 1988-02-22 |
| AU7475981A (en) | 1982-03-11 |
| EP0047016A1 (en) | 1982-03-10 |
| ES518145A0 (es) | 1984-05-01 |
| JPH0261480B2 (es) | 1990-12-20 |
| ES8404375A1 (es) | 1984-05-01 |
| ES8506046A1 (es) | 1985-07-01 |
| ZA815963B (en) | 1982-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT76307A (fr) | Procede de preparation de nouveaux derives 3-ceto delta 4,9 19-nor steroides | |
| ES479206A1 (es) | Un procedimiento para la preparacion de n-heterociclil-4- piperidinamina. | |
| JPS5412381A (en) | N-alkylpiperidine derivative | |
| DE3477791D1 (en) | Nucleoside process | |
| ES8207584A1 (es) | Procedimiento para el desdoblamiento enzimatico de acido d, l-2-amino-4-metilfosfinobutirico. | |
| IL63775A (en) | Process for decomposing 2,4-dihydroxy-6-amino-s-triazine derivatives by pseudomonas strains | |
| JPS52286A (en) | Method of preparing 1-(3-phenylpropyl)-4-acylpiperazine derivatives | |
| IL54761A (en) | Process for the isolation of alkaloid components from the plant vinca rosea l. | |
| ES8506046A1 (es) | Procedimiento para preparar 18-sustituidas pregn-4-ene-3, 20-dionas y compuestos especificos de 18-etinilpregn- y vinilidenopregn-4-eno-3, 20-diona | |
| PT73360B (fr) | Procede de preparation de steroides 17alpha hydroxy 20-ceto | |
| JPS56131396A (en) | Microbiological method for converting steroid compound | |
| HU179593B (en) | Process for producing 9-alpha-chloro-11-beta,17-dihydroxy-pregna-1,4-diene-3,20-dione derivatives | |
| IE821783L (en) | 9-hydroxypregnadiene derivative | |
| MX9300677A (es) | Procedimiento mejorado para la preparacion de dienos esteroidales substituidos. | |
| JPS5236654A (en) | Process for preparation of steroid derivatives | |
| SU605650A1 (ru) | Способ прокатки труб на редукционном стане | |
| JPS5221168A (en) | Process for producing soil conditioner by fermenting bark | |
| AU499324B2 (en) | D-homo pregna 1, 4 diene-3, 11, 20 trione derivatives | |
| AU507195B2 (en) | Pipe anda Method for its Manufacture | |
| JPS51150852A (en) | Method for installing outside frames for fittings independently | |
| JPS52249A (en) | Process for preparing novel bicyclo 4.3.0 nonane derivatives | |
| AU493178B2 (en) | Method for controlling the growth of plants | |
| YU21779A (en) | Process for obtaining new steroids of the pregnane series, substituted in position 17 | |
| PL248306A2 (en) | Process for preparing 21-acetate of 6-aplha-methyl-17-alpha,21-dohydroxy-4-pregnen-3,20-dione | |
| JPS51130579A (en) | Process for assimilating and decomposing of polyvinyl alcohol by the u se of microorganisms |